RenovoRx, Inc. (RNXT)
1.23
+0.03
(+2.50%)
USD |
NASDAQ |
Oct 21, 16:00
1.235
0.00 (0.00%)
After-Hours: 20:00
RenovoRx Net Income (Annual) : -11.17M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -11.17M |
| December 31, 2024 | -8.814M |
| December 31, 2023 | -10.23M |
| December 31, 2022 | -9.889M |
| Date | Value |
|---|---|
| December 31, 2021 | -6.324M |
| December 31, 2020 | -3.798M |
| December 31, 2019 | -3.839M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Enanta Pharmaceuticals, Inc. | -81.89M |
| Travere Therapeutics, Inc. | -50.26M |
| REGENXBIO, Inc. | -193.88M |
| Krystal Biotech, Inc. | 204.83M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |